PHASE 3 TRIAL OF SUBCUTANEOUS EPCORITAMAB + R‐CHOP VERSUS R‐CHOP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): EPCORE DLBCL‐2

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 41; no. S2; pp. 849 - 850
Main Authors Sehn, L. H, Chamuleau, M., Lenz, G., Clausen, M. R., Haioun, C., Izutsu, K., Davies, A., Zhu, J., Oki, T., Szafer‐Glusman, E., Conlon, R., Chiou, H., Ipe, D., Elliot, B., Wu, J., Salles, G.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2023
Subjects
Lymphoma
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.3166_OT28